A Review on CRISPR/Cas9 as a Novel Technique for Cancer Therapy

Q4 Medicine

Cellular Therapy and Transplantation Pub Date : 2022-12-29 DOI:10.18620/ctt-1866-8836-2022-11-3-4-10-24

Ali A. Saleem, Khalida K. Al-Kelaby

引用次数: 0

Abstract

as the problems that can be encountered during clinical investigations. In this regard, we intend to contribute to optimizing work on CRISPR/Cas9 as well as to focus on the probable future paths of this technology.

查看原文本刊更多论文

CRISPR/Cas9作为肿瘤治疗新技术的研究进展

在临床调查中可能遇到的问题。在这方面，我们打算为优化CRISPR/Cas9的工作做出贡献，并专注于这项技术可能的未来路径。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cellular Therapy and Transplantation Medicine-Transplantation

CiteScore

0.60

自引率

0.00%

发文量